DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 201 filers reported holding DEPOMED INC in Q1 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $856,000 | +1.2% | 128,313 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $846,000 | -18.1% | 128,313 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $1,033,000 | +39.0% | 128,313 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $743,000 | -46.1% | 128,313 | 0.0% | 0.00% | -50.0% |
Q2 2017 | $1,378,000 | -14.4% | 128,313 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $1,610,000 | -35.1% | 128,313 | -6.8% | 0.00% | -33.3% |
Q4 2016 | $2,480,000 | -28.2% | 137,613 | -0.5% | 0.01% | -33.3% |
Q3 2016 | $3,456,000 | +26.5% | 138,313 | -0.6% | 0.01% | +28.6% |
Q2 2016 | $2,731,000 | +33.2% | 139,213 | -5.4% | 0.01% | +40.0% |
Q1 2016 | $2,051,000 | -23.0% | 147,213 | +0.2% | 0.01% | -28.6% |
Q4 2015 | $2,664,000 | -3.3% | 146,913 | +0.5% | 0.01% | -12.5% |
Q3 2015 | $2,754,000 | -12.1% | 146,113 | +0.1% | 0.01% | 0.0% |
Q2 2015 | $3,132,000 | +36.9% | 145,947 | +43.0% | 0.01% | +33.3% |
Q1 2015 | $2,287,000 | -14.7% | 102,050 | -38.6% | 0.01% | +100.0% |
Q4 2014 | $2,680,000 | +222.5% | 166,300 | +204.1% | 0.00% | +50.0% |
Q3 2014 | $831,000 | – | 54,679 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DELTEC ASSET MANAGEMENT LLC | 2,252,402 | $31,376,000 | 7.88% |
Healthcare Value Capital, LLC | 350,000 | $4,876,000 | 7.16% |
Senvest Management, LLC | 4,977,256 | $69,333,000 | 5.82% |
Consonance Capital Management LP | 2,756,360 | $38,396,000 | 5.81% |
Opaleye Management Inc. | 325,000 | $4,527,000 | 2.82% |
Krensavage Asset Management, LLC | 447,000 | $6,227,000 | 2.23% |
Healthcare Value Capital, LLC | 100,000 | $1,393,000 | 2.05% |
Starboard Value LP | 2,950,000 | $41,094,000 | 1.44% |
HealthInvest Partners AB | 200,000 | $2,786,000 | 1.30% |
OAK RIDGE INVESTMENTS LLC | 7,206,286 | $100,384,000 | 1.29% |